Literature DB >> 3458227

Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.

R R Weichselbaum, W Dahlberg, M Beckett, T Karrison, D Miller, J Clark, T J Ervin.   

Abstract

Inherent cellular radioresistance and repair of x-ray damage was studied in 19 early-passage squamous cell carcinoma lines derived from head- and neck-cancer patients with known clinical results following radiotherapy. Human tumor cells that were radioresistant and/or proficient in accumulation/repair of x-ray damage were cultured from patients unsuccessfully treated with radiotherapy. Thus, the presence of radiation-resistant and repair-proficient tumor cells was associated with clinical radiation failure, suggesting the possibility of a predictive assay based on in vitro radiobiological parameters.

Entities:  

Mesh:

Year:  1986        PMID: 3458227      PMCID: PMC323364          DOI: 10.1073/pnas.83.8.2684

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  X-ray damage and recovery in mammalian cells in culture.

Authors:  M M ELKIND; H SUTTON
Journal:  Nature       Date:  1959-10-24       Impact factor: 49.962

2.  In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice.

Authors:  I E Smith; V D Courtenay; J Mills; M J Peckham
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

3.  The radiation response of human malignant melanoma cells grown in vitro.

Authors:  S C Barranco; M M Romsdahl; R M Humphrey
Journal:  Cancer Res       Date:  1971-06       Impact factor: 12.701

4.  Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells.

Authors:  J B Little
Journal:  Nature       Date:  1969-11-22       Impact factor: 49.962

Review 5.  Fractional dose radiotherapy and its relationship to survival curve shape.

Authors:  M M Elkind
Journal:  Cancer Treat Rev       Date:  1976-03       Impact factor: 12.111

6.  Predicting radiocurability.

Authors:  L J Peters; W Brock; T Johnson
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

7.  X-ray sensitivity of human tumor cells in vitro.

Authors:  R R Weichselbaum; J Nove; J B Little
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-04       Impact factor: 7.038

8.  Human tumor colony assay and chemosensitivity testing.

Authors:  S E Salmon
Journal:  Cancer Treat Rep       Date:  1984-01

9.  Resistance to methotrexate due to gene amplification in a patient with acute leukemia.

Authors:  M D Carman; J H Schornagel; R S Rivest; S Srimatkandada; C S Portlock; T Duffy; J R Bertino
Journal:  J Clin Oncol       Date:  1984-01       Impact factor: 44.544

10.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

View more
  40 in total

1.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

2.  Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN.

Authors:  D E Hallahan; V P Sukhatme; M L Sherman; S Virudachalam; D Kufe; R R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

Authors:  Zhiyong Mao; Ying Jiang; Xiang Liu; Andrei Seluanov; Vera Gorbunova
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.

Authors:  Rosemarie Krupar; Katharina Robold; Doris Gaag; Gerrit Spanier; Marina Kreutz; Kathrin Renner; Claus Hellerbrand; Ferdinand Hofstaedter; Anja K Bosserhoff
Journal:  Virchows Arch       Date:  2014-07-16       Impact factor: 4.064

5.  Cytogenetic analyses of a murine carcinoma cell line and six metastatic derivatives with different degrees of radioresistability.

Authors:  R J Jamasbi; M Q Ye; T M Norvell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

6.  Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.

Authors:  D E Hallahan; D R Spriggs; M A Beckett; D W Kufe; R R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC.

Authors:  Elise V M Fletcher; Laurie Love-Homan; Arya Sobhakumari; Charlotte R Feddersen; Adam T Koch; Apollina Goel; Andrean L Simons
Journal:  Mol Cancer Res       Date:  2013-09-18       Impact factor: 5.852

8.  A new role for cortactin in invadopodia: regulation of protease secretion.

Authors:  Emily S Clark; Alissa M Weaver
Journal:  Eur J Cell Biol       Date:  2008-03-14       Impact factor: 4.492

9.  Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.

Authors:  M Hedman; T Björk-Eriksson; O Brodin; I Toma-Dasu
Journal:  Br J Radiol       Date:  2013-03-11       Impact factor: 3.039

10.  Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

Authors:  E S Clark; B Brown; A S Whigham; A Kochaishvili; W G Yarbrough; A M Weaver
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.